NOV 05, 2020 7:30 AM PST

Keynote Presentation: The Opioid Crisis: Made in America...Fade in America

Presented at: Opioid Crisis 2020
C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

The opioid crisis is a uniquely American challenge. Many factors catalyzed this national nightmare and others continue to fuel it. This presentation delves into some of the major contributors, offer suggestions for reducing this deadly public health problem, and describe challenges for implementation.   The United States stumbled into a series of imprudent decisions can be instructive: it is feasible to “reverse-engineer” past mistakes; it is  important to compile a  “lessons learned” list, a cautionary tale for future drug crises. The initial stimulus, overprescribing of pain-killers, is being gradually reversed, albeit now requiring thoughtful actions to prevent unintended consequences. Responses cannot remain stagnant and locked into fixed solutions, as emerging trends continue to challenge old premises. Illicit fentanyl and heroin now are the two leading contributors to overdose deaths, alone or combined with psychostimulant drugs such as cocaine and methamphetamine.  Prevention strategies based on reducing supply of fentanyl/heroin/cocaine/methamphetamine are clearly different from those involving prescription opioids. Universal principles of treatment, alternatives for pain management, evidence-based treatment involving medications, rescue, and long-term recovery support can be applied to those with an opioid use disorder regardless of chemical class of opioids. Nonetheless, challenges to implementation abound, from resistance to change, stigma, scalability and effective transitions of care.

Learning Objectives:

1. Understand why the opioid crisis is a uniquely American challenge

2. Learn at least 4 factors (of  > 32 factors) that fueled the opioid crisis

3. Lessons learned that can be applied to emerging drug threats

4. Learn 12 principles of treatment and weaknesses in current system


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
OCT 21, 2021 9:00 AM PDT
C.E. CREDITS
OCT 21, 2021 9:00 AM PDT
Date: October 21, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Industry guidelines for host cell protein impurity analysis emphasize the importance of process-specific and product-specific assessm...
Loading Comments...
Show Resources